Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Please include your organization in your Zoom name.
- Click on your picture/name in Zoom
- Click on rename
- enter <name> - <organization>
Name | Organization | Present |
---|---|---|
Danielle Bancroft | Best Practice Software | |
Melva Peters | Jenaker Consulting | x |
Jean Duteau (Chair) | Duteau Design | x |
John Hatem (Scribe) | Independent Consultant | x |
Scott Robertson | Kaiser Permanente | |
Christof Gessner | HL7 Germany | |
Corey Spears | MITRE | |
Dave Hill | MITRE | |
Frank McKinney | POCP | x |
Isaac Vetter | Epic | |
Joseph Quinn (Joe) | Smile CDR | x |
Lawrence Lo | Columbia University HIT Student | |
Margaret Weiker | NCPDP | x |
Matt Szczepankiewicz | Epic | |
Peter Sergent | HL7 New Zealand | |
Reed D. Gelzer | Trustworthy EHR | |
Shelly Spiro | Pharmacy HIT Collaborative | x |
Stephen Chu | ADHA | |
Tim McNeil | Surescripts | x |
Kim Roberts | Pharmacy HIT Collaborative | |
Kent Bulza | Well Health | |
Phung Matthews | 3M | |
Jack Brashier | Epic | |
Emmanuel Obasuyi | ||
Joel Montavon | PQA | |
Robb Young | PharmID | |
Christopher Isong | ||
Gary Schoettmer | NetRx | |
Courtney Bland | CVS / Aetna | |
Mark Neumuth | Aetna | |
Ed Millikan | FDA | |
Sanket Raval | CVS / Aetna |
Agenda Items and Notes
Outstanding Action Item List
Meeting Notes from previous meeting
- 2022-08-29 Agenda/Meeting Notes - approved by general consent
Project Review
Project Proposals
- Project Proposals in Review - nothing to review
Project Scope Statements
- Project Scope Statements - nothing to review
External Meeting Review
Catalog Updates (John Hatem)
- - no meeting on 9/12, next meeting is on 9/16
Workflow Update (John Hatem)
- - unable to attend, will update after minutes are posted.
Healthcare Product Update (John Hatem)
- - unable to attend, will update after minutes are posted
EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)
- - no meeting
NCPDP Updates (NCPDP Members)
All NCPDP Meeting information can be obtained at https://dms.ncpdp.org/
- - no new NCPDP issues
Projects
Pharmacist Consult Note (Scott)
- - Currently under ballot (closes Sept 12)
Pharmacy Templates
- - Currently under ballot (closes Sept 12)
- Georgio will not be attending the WGM, so we may discuss this during one of weekly conference calls
Specialty Medication Enrolment IG
- - Currently under ballot (closes Sept 12)
- Frank reported that were several comments at this point. Stats to be discussed on Monday Q3
Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)
- Update of R5 Pharmacy content - sign up for R5 ballot
- FHIR-37974 - Motion to accept resolution by John Hatem / Melva Peters Vote passed: 7-0-0 see tracker for details
- FHIR-37973 - Motion to accept resolution by Melva Peters / John Hatem Vote passed: 7-0-0 - see tracker for details
WGM Agenda
WGM Agenda - meeting Mond Q3, Thu Q2, Thu Q4. Joint with BR&R Mon Q1, Tue Q1. Attending FHIR-I Tue Q2. Attending PC Wed Q4. Attending CQI/CDS Thu Q1.
Any Other Business
- will anyone be able to attend the HL7 Catalog meeting on Sept 16th.
- John will send out a link to the meeting to the Pharmacy list serv
Next meeting:
- (2nd week after the WGM)